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INTRODUCTION 
Colorectal cancers are one of the most common malignancies 
globally. The incidence  is high  in  North  America,  North  West  
Europe  and  Australia  as  against  Asia  and  South  America.  However  
regular  practice  of  screening  has  led  to  fall  in  mortality  rates.  On  
the  contrary,   adoption  of  western  lifestyle  in  some  countries  has  
lead to steady  increase  in  occurrence  of  colorectal  cancer.  Sporadic  
colorectal  carcinomas  are  closely  associated  with  modifiable  risk  
factors  like  diet,  lifestyle  and  genetic  susceptibility. The  peak  age  
group  affected  is  around  65  yrs. 
The distribution of colorectal cancer  varies  with  age  and  gender.  
Right  colon  is  more  commonly  affected  in  females  of  all  ages.  
Hence evolution of colorectal cancer is multifactorial.  A large proportion 
of carcinomas arise from adenomas. Precancerous  lesions  include  
familial  adenomatous  polyposis  and  chronic  inflammatory  bowel  
disease. Inherited  colorectal  cancers  occur  at  relatively  younger  age  
and  are  commonly  multifocal.  They  are  associated  with  malignancy  
of  other   organs  like  uterus,  stomach  and  brain. The presentation of 
colorectal cancer varies with site of involvement.  Bleeding  per  rectum  
is  more  common  with  right  sided  tumours  in  contrast  to  altered  
bowel  habits  for  left  sided  tumours. 
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Colorectal  cancers  spread  to  regional  lymph  nodes,  liver  and  
omentum  by  lymphatics,  veins  and  transcoelomic  route  respectively.    
Inoperable cases have poor  prognosis.  Systematic reporting is 
crucial for defining  protocols.  Inspite  of  all  treatment  regimens,  cure  
rate  is  50%  which  is  explained  by  micrometastasis  that  often  eludes  
discovery.  Proper  sampling  of  specimens  and  keen  observation  of  
slides  is  vital  to  determine  prognosis. 
Immunohistochemistry is useful to exclude non intestinal 
adenocarcinomas.  Molecular  studies  have  emerged  in  the  forefront  
in  well  established  institutions  so  that  complete  work  up  is  done.  
Of  particular  interest  is  sporadic  cancers  with  microsatellite  
instability  as  they  have  good  prognosis.  In  the  coming  years  further  
explorations  can  reveal  unseen  mysteries  in  evolution  of  colorectal  
cancer.       
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AIM AND OBJECTIVES 
AIM: 
     Aim  of  the  study  is  to  evaluate  the   peritoneal  elastic  lamina  
invasion  and  extramural  venous  invasion  in  T3  colorectal  cancer  
and  its  significance  in  staging. 
OBJECTIVES: 
1. To identify the peritoneal elastic lamina and its invasion in  
colorectal cancer with  elastic  stain. 
2. To assess the incidence of peritoneal elastic lamina invasion in T3 
colorectal cancer. 
3. To assess the correlation between extramural venous invasion and 
tumour staging. 
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                             REVIEW OF LITERATURE  
INTRODUCTION 
           Colorectal cancer is a common cause of morbidity and mortality 
Worldwide
(1)
. Epidemiological and genetic factors influence the 
occurrence of  colorectal  cancer.  The  incidence  is  maximum  at  60-70  
yrs  of  age  with  fewer  cases  occurring  before  the  age  of  50  yrs.   
EPIDEMIOLOGY: 
           Colorectal  cancer  is  the  third  most  commonly  diagnosed   
cancer  in  males  and  second  in  females.  A substantial  number  of  
new  cases  (1.2  million  cases)  are  diagnosed  each  year.  Gender wise  
males are more predisposed than females. The incidence varies   
markedly across the world. Approximately 95% of colorectal   
carcinomas  are adenocarcinoma.  Others  are  mucinous  carcinomas  and  
adenosquamous  carcinomas. 
The  incidence  of  right   sided  colon  cancers  has  increased  and 
these  patients have shorter  survival  time.  The  American  Society  of  
Clinical  Oncology(ASCO)  defined  right  sided  colon  cancers  as  
cancer  of caecum  and  ascending  colon  upto  the   hepatic  flexure.  
Left  sided  colon  cancer  comprises  involvement  of  splenic  flexure  
and  regions  distal  to  it  including  rectum.     
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REVIEW OF LAYERS OF COLONIC WALL 
Colon  and  rectum  has  four  layers.   
 Mucosa  
 Submucosa 
 Muscularis  propria 
 Serous  layer 
 
 MUCOSA: 
Epithelium,  lamina  propria  and  muscularis  mucosae  forms  the  
mucosal  layer.  The  epithelium  is  lined  by  single  layer  of  cuboidal  
to  low  columnar  cells.  They  have  two  types  of  cells  which  are  
absorptive  cells  and  goblet  cells.   
Absorptive  cells  have  acidophilic  cytoplasm,  basally located  
nuclei  and  apical  striated  borders.  Goblet  cells  have  mucin  granules.  
Crypts  which  are  placed  parallel  to  one  another  are  tubular  shaped.  
Paneth  cells  and  endocrine  cells  are  seen  in  the  crypts.  They  are  
seen  in  caecum  and  right  colon. 
Lamina  propria  has  a  network  of  collagen  fibres,  blood  
vessels,  nerves  and  smooth  muscle  bundles.  They  also  contains  
some  lymphocytes,  plasma  cells,  mast  cells  and  histiocytes. 
Muscularis  mucosae  which  is  made  up  of  smooth  muscle  fibres  
separates  mucosa  and  submucosa.     
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 SUBMUCOSA: 
 It contains connective  tissue,  blood  vessels,  lymphatics,  glands  
and  nerves. 
 MUSCULARIS PROPRIA: 
Outer  longitudinal  muscle  layer  and  inner  circular  muscle  
layer  forms  the  muscularis  propria 
 SEROUS  LAYER: 
 Single  layer  of  flattened  to  cuboidal  mesothelial  cells   forms  
the  serous  layer.  
ETIOLOGY OF COLONIC CARCINOMA: 
NON  MODIFIABLE  RISK  FACTORS: 
 AGE  
The  incidence  of  colorectal  cancer  increases  after  40  yrs  of  
age . 
ADENOMATOUS POLYP 
Colorectal  cancer  can  arise  from  tubular  adenoma  and  villous  
adenoma within  a  span  of  5  to 10  yrs. Sporadic  colorectal  cancers  
arise   from   these  adenoma. 
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INFLAMMATORY BOWEL DISEASE 
The  two  inflammatory  bowel  diseases  in  risk  for  colorectal  
carcinoma are  crohns  disease  and  ulcerative   colitis. Crohns  disease  
is  characterised  by  inflammation  of  full  thickness  of  the  bowel  
wall. Ulcerative  colitis  is  characterized  by  inflammation  of  mucosa  
of  colon  and  rectum and the risk of malignancy was higher for late 
onset disease and extensive colitis. 
FAMILY HISTORY 
There  is  increased  risk  of  getting  colorectal  cancer  in  
individuals   with  positive  family  history. 
GENETIC FACTORS 
Following are the inherited conditions associated with colorectal 
cancer 
a) Familial adenomatous  polyposis 
 
It is an autosomal dominant disorder having high degree of 
penetrance. It is due to mutation in APC (Adenomatous  Polyposis  Coli)  
gene
(2)
. Some cases are associated with mutation in MYH (Myosin Heavy 
Chain) gene. Grossly it presents with numerous polyps involving gastro  
intestinal tract, stomach and  small  bowel.  Ulceration  at  the  surface  of  
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the  polyp  should  arouse   suspicion  of   malignant  transformation  in  
the  polyp. If  left  untreated,  there  is  100%  risk   of  developing  
colorectal  carcinoma  in  FAP  patients often   by  the  age  of  30  and  
nearly  always  by   the  age  50.FAP  is  also  associated with multiple 
endocrine neoplasia, hepatoblastoma and  nasopharyngeal angiofibroma. 
One  of  the  variants   of  FAP  is  hereditary  flat  type  adenoma  
where  the  polyps  are  flat  with  right  sided  colonic  preponderance. 
b) Hereditary  non  polyposis  colorectal  cancer 
They  have  mutation  in   DNA  mismatch  repair  genes  most  
commonly MLH1 (MutL Homolog 1),  MSH2  (MutS  protein  Homolog  
2), MSH6   (MutS  Homolog  6)  and  PMS2(Post  Meiotic  Segregation  
Increased, S.Cerevisiae ,2)
(3)(5)
. The first degree relative has a 50% risk  
of developing colorectal cancer. They can also present with malignancy 
in other sites such as uterus, bladder, liver etc..  Peutz  jegher  syndrome,  
cowden syndrome, turcot syndrome, torre muir  syndrome  are  the  other  
associated  inherited syndromes with colorectal cancer
(4)
.   
MODIFIABLE RISK FACTORS 
DIETARY FACTORS 
High intake of refined carbohydrates, fat and low intake of 
vegetable fibres can lead to colorectal cancer.  Whole grains, fish oil, 
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vitamin D, calcium supplements and physical activity can reduce the risk 
of developing colorectal cancer. 
OBESITY AND PHYSICAL INACTIVITY  
Excess  weight  and  lack  of  physical  activity  increase  the  risk  
of  developing  colorectal  cancer 
ALCOHOL CONSUMPTION 
There  is  an  increased  risk  of  developing  colorectal  carcinoma  
in patients  consuming  alcohol  especially at young age.  
IRRADIATION 
There  is  an  increased  risk  of  developing  colorectal  cancer  in 
individuals   exposed  to  therapeutic  pelvic  irradiation. 
PATHOGENESIS: 
The  molecular  events  that  result  in  colorectal  carcinoma  
include genetic  abnormalities  and  epigenetic  abnormalities.   The  most  
common genetic  abnormality  seen  in  sporadic  colon  is  mutation  in  
APC gene. Normally APC  protein  binds  to  beta  catenin  and  degrades  
them.  If mutation  in  APC  protein  occurs,  the  beta  catenin  will  not  
be  degraded and  it  will  be  translocated  to  the  nucleus  where  it  
binds  with  the  DNA   leading  to  transcriptional  activation  of  MYC  
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and  cyclin  D1.  This results in uncontrolled proliferation of  tumor  cells. 
In some individuals beta catenin mutation by itself can  cause  colorectal  
cancer. 
TP53  mutation  and  inactivation  of  gene  is  seen  in  50%  to  
70%  of  Colorectal  cancer.  These are more commonly seen in distal  
colorectal cancer.  If  P53  mutation  is  found  in  proximal  tumours  
they  more  often exhibit  lymphatic  invasion.  Mutation  associated  with  
exon  5  region  of the  TP53  gene  carries  poorer  outcome.  Wild  type  
TP53  shows  good response  with  5FU  therapy  especially  if  it  
involves  rectal  region.  There  is no  strong  data  in  supporting  the  role  
of  TP53  as  a  prognostic  or predictive  marker  in  colorectal  cancer.  
K-RAS  mutation  is  seen  in  40%   of  colorectal  cancer
(6)(7)
.  It  
does  not  have  prognostic  value  in  stage  2  and  3  colorectal  cancer. 
Genomic instability also contributes to colorectal cancer.  It can be 
Chromosomal instability or microsatellite instability. Chromosomal 
abnormality which is the commonest genome instability includes 
aneuploidy, gain or loss of chromosomal material and translocation.  
Microsatellite instability is found in 15% of colorectal cancer. 
Microsatellite sequences are located  in  the  coding  or  promoter  regions  
of genes which are involved in the regulation of cell growth
(76)
. If  
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mutation accumulates  in  microsatellites,   uncontrolled  cell  growth  and 
enhanced survival of genetically abnormal clones can occur.   
Microsatellite instability is due to defect in the DNA mismatch repair  
genes
(8)
.   
Patients with  microsatellite  instability  carry  good  prognosis.  
They have  specific  characteristics  which include their  tendency  to  
arise  in  the  proximal colon,  lymphocytic  infiltrate,  mucinous  or  
signet  ring  appearance  and poorly  differentiated grade
(9)
.  The  tumor  
cells  in  microsatellite  instability associated  colorectal  cancer  are  
diploid  and  have  less  loss  of heterozygosity .   
MSI  is  divided  into  MSI- H(Micro  Satellite   Instability  High)  
when  there  is  >30%  of    microsatellite  marker  mutation  and  MSI-L 
(Micro  Satellite  Instability  Low)  when  there  >1%  to  <30%  o 
microsatellite  marker  mutation.  Apart  from  MSI-H  and  MSI-L  there  
is another  type  called  EMAST  which  is  elevated  microsatellite  
alterations  at selected  tetranucleotide  repeats  which  is  frequently  
found  in  non  colonic  tumors.  EMAST is found to be associated with 
TP53 mutation. EMAST was also found to be associated with 
microsatellite stable colorectal cancers.   
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 Colorectal carcinomas also demonstrate hypermethylation of CpG. 
This plays an important role in the inactivation of tumor suppressor  
genes  such  as  TP16  and  CDH1. 
Few of the colorectal carcinomas also demonstrate increased CpG 
island  methylation. MSI tumors can  arise  from  CpG  island  methylated 
tumors
(10)
. There can be hypermethylation  and  hypomethylation. CIMP  
is divided  into  CIMP-H  and  CIMP-L
(77)
.  CIMP-H  is  associated  with  
BRAF mutation  whereas  CIMP-L  is  associated  with  KRAS  mutation.  
If  CIMP tumours  are  associated  with  MSI  instability  it  carries  good  
prognosis.CIMP   tumours  with  MSI  negativity  have  poor  prognosis. 
BRAF mutation is seen in 10% of colorectal cancer
(72)
. BRAF 
mutation is due to V600E amino acid substitution.  It is an independent  
biomarker for colorectal cancer exclusive of KRAS mutation
(11)
. If  
BRAF mutation is present in an MSI tumour then the chance of  
hereditary association is unlikely.   
WHO CLASSIFICATION OF COLORECTAL TUMOUR 
EPITHELIAL TUMOURS 
 Adenoma8140/0 
     
● Tubular8211/0 
● Villous8261/0 
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● Tubulovillous 8263/0 
● Serrated8213/0 
 
Intraepithelial  neoplasia2(dysplasia) 
Associated with chronic inflammatory diseases 
● Low  grade  glandular  intraepithelial  neoplasia 
 
● High  grade  glandular  intraepithelial  neoplasia 
Carcinoma 
● Adenocarcinoma8140/3 
● Mucinous  adenocarcinoma8480/3 
● Signet  ring  cell carcinoma8490/3 
● Small  cell  carcinoma8041/3 
● Squamous  cell  carcinoma8070/3 
● Adenosquamous  carcinoma8560/3 
● Medullary  carcinoma8510/3 
● Undifferentiated  carcinoma8020/3 
● Carcinoid (well  differentiated  endocrine  
neoplasm)8240/3 
● EC-cell,  serotonin-producing  neoplasm8241/3 
● L-cell,glucagon  like  peptide  and  PP/PYY  producing 
tumour 
● Others 
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NON-EPITHELIAL TUMOURS  
 Lipoma8850/0 
 Leiomyoma8890/0 
 Gastro  intestinal  stromal  tumour8936/1 
 Leiomyosarcoma8890/3 
 Angiosarcoma9120/3 
 Kaposi  sarcoma9140/3 
 Malignant  melanoma8720/3 
 others 
 
Malignant  lymphomas 
 
● Marginal  zone  B  cell  lymphoma  of  MALT  type9699/3 
● Mantle  cell  lymphoma9673/3 
● Diffuse  large  B-cell  lymphoma9680/3 
● Burkitt  lymphoma9687/3 
● Burkitt  like/atypical  Burkitt  lymphoma9687/3 
● Others 
 
SECONDARY TUMOURS 
POLYPS 
Hyperplastic  (metaplastic) 
Peutz –jeghers 
Juvenile
(12) 
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PRECURSOR NEOPLASTIC LESIONS 
1. Adenoma 
2. Hyperplastic  polyps 
3. Juvenile  polyp 
4. Inflammatory  polyps 
5. Aberrant  crypt  foci 
6. Chronic  inflammatory  bowel  disease 
ADENOMA 
Adenomas   are  the  precursor  lesions   of  colorectal  carcinoma 
These  are  characterised   by   the  presence  of  intraepithelial  neoplasia. 
Histologically  there  will  be  increased  cellularity,  loss  of  polarity,  
nuclear  stratification  and  enlarged  hyperchromatic  nuclei. Based  on  
the  degree  of  villous or  glandular  pattern,  severity  of  nuclear  details  
and  extent  of  nuclear  stratification, they are categorized  into  low  
grade  and  high  grade. Macroscopically they are divided into 
 
● Depressed  adenoma 
● Flat  adenoma 
● Elevated  adenoma
(13) 
Histopathologically they are divided  into 
● Tubular  adenoma 
● Villous  adenoma 
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● Tubulovillous  adenoma 
TUBULAR ADENOMAS 
 These are flat or pedunculated lesions and  are  typically  spherical. 
Microscopically  these  are  characterised  by  the  presence  of  more   
than  80%  of  dysplastic glandular  structures  in  their  luminal  surface. 
VILLOUS ADENOMAS 
These are sessile with hairy appearing surface.  Microscopically  
80%  of  their  luminal  surface  show  leaf  like  projection  which  are  
lined  by  dysplastic  epithelium
(14)
  
TUBULOVILLOUS ADENOMA 
They show both tubular and villous pattern 
SERRATED ADENOMA  
 These  are  hyperplastic  polyp  with  saw  tooth  surface.  
Dysplastic  changes  are  seen  in  the  epithelial  lining  of  the  luminal  
surface  and  upper  portion  of  the  crypts.
(15) 
HYPERPLASTIC POLYP 
  These  are  nodular  mucosal  protrusions  more  commonly  seen  
in  the  left  colon  .They   have  serrated  surface  due  to  epithelial  
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overcrowding   and  serrations  are  seen  only  upto  upper  third  of  the  
luminal  surface. They  have  elongated  crypts  with  mature  goblet   
cell  at  their  upper  portion  and  proliferative  epithelium  at  their  lower  
portion. 
JUVENILE POLYPS 
 Juvenile polyps are more commonly seen in children under 5 yrs  
of age group
(16)
. These can be syndrome associated or sporadic
(25)(26)
.  
Sporadic polyps are usually solitary whereas syndrome associated  polyps  
are multiple in number. Macroscopically these are  pedunculated  reddish  
smooth surfaced lesions  with  numerous  cystic  spaces.  Microscopically  
they have numerous dilated cystic glandular structures with inflammatory  
cell collection in the lamina propria. 
 INFLAMMATORY POLYPS 
 These are characterised  by  epithelial erosion,  hyperplasia, mixed  
inflammatory  infiltrate  and  fibromuscular  hyperplasia  in  the  lamina  
propria. 
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ABERRANT CRYPT FOCI (ACF) 
Aberrant crypt foci are clusters of abnormal crypts that precede  the  
development  of  adenomas. These foci are apoptosis  resistant.  But  their  
relevance to cancer is controversial. MDF (mucin depleted foci),  BCAC 
(beta catenin accumulated crpts), flat ACF,  dysplastic ACF have been  
identified as early lesions that develop into colorectal carcinoma. ACF  
and MDF are microscopically visible in unsectioned  colon  stained  with  
methylene  blue - high  iron diamine and alcian  blue  respectively 
HISTOPATHOLOGICAL TYPES IN COLORECTAL CANCER 
    Adenocarcinoma  NOS 
    Mucinous  adenocarcinoma 
    Signet  ring  carcinoma 
    Small  cell  carcinoma 
    Micropapillary  adenocarcinoma 
    Serrated  adenocarcinoma
(17)(18) 
    Cribriform   type  adenocarcinoma 
    Adenosquamous  carcinoma 
    Squamous  cell  carcinoma 
    Medullary  carcinoma
(19) 
    Undifferentiated  carcinoma       
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ADENOCARCINOMA 
Adenocarcinoma  is the most common  type.Macroscopically  it  
can  be  exophytic,  endophytic, annular (circumferential  involvement  of  
bowel wall) and diffusely infiltrative lesion. Based on glandular  
differentiation they are classified into 
a. Grade  1  -  Well  differentiated(>  95%  of  the  tumor  cells  show               
glandular   formation 
b. Grade  2  -  Moderately  differentiated(glandular  formation  is  
seen  in 50- 95%  of  the  tumour  cells. 
c. Grade  3  -  poorly  differentiated  (glandular  formation  is  seen  in  
<50%  of  the  tumor  cells      
Grade I and II are low grade tumour, Grade III is a high grade tumour  
Variants: 
 1. MUCINOUS ADENOCARCINOMA: 
It  is  seen  in  about  15%  of  colorectal  carcinoma  which  mainly  
affects  rectum.  Grossly  seen  as  exophytic  growth  with  visible mucin.  
When  more  than  50%  of  the  tumour  cells  show  mucin  it  is  termed  
as  mucinous  adenocarcinoma
(20)
.  Adenocarcinoma  with  mucinous 
differentiation  is  termed  when  10-15%  of  the  tumour  cells  show 
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mucinous  component.  It  is  characterised  by  malignant  epithelial  
cells  with  pools  of  extacellular  mucin.  Mucinous  adenocarcinoma  
have  high levels of microsatellite  instability  and have  poor  prognosis.  
SIGNET RING CARCINOMA: 
         It  is  one  of  the  rare  variant  of  colorectal  carcinoma  and  it  is  
otherwise  called  as  Linitis  plastica-type  colorectal  carcinoma.  It  is  
seen  in  young  patients.  Grossly  seen  as  diffusely  infiltrative  lesion.  
Microscopically  tumour  cells  seen  as  nests,  infiltrative  cords   and  
diffuse  sheets.  When  more  than  50%  of  the  tumour  cells  have  
intracytoplasmic  mucin  it  is  termed  as  signet  ring  cell  carcinoma.  
Metastsis  occur  in  ovary,  lymph  node  and  peritoneal  surface.  It  has  
poor  prognosis
(21)
. 
MICROPAPILLARY VARIANT: 
Micropapillary variant accounts for about 20% of colorectal  
cancer.  It has high risk for lymph node metastasis and  lymphovascular  
invasion. 
SERRATED ADENOCARCINOMA 
         It  accounts  for  about  7.5%  of  all  colorectal  tumours  and  arise  
from  serrated  adenoma  showing  serrated,  trabecular  and  mucinous  
pattern. 
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ADENOSQUAMOUS CARCINOMA: 
Adenosquamous carcinoma is one of the rare tumour more 
commonly seen in caecum. They show both squamous and glandular  
differentiation.   
Both  component  can  be  seen  admixed  together  or  seen  as  
separate  areas.  Pure  squamous  cell  carcinoma  is  very  rare. 
MEDULLARY  CARCINOMA: 
        It  is  one  of   the  rare  variant  commonly  seen  in  females  which  
mainly affects  the  right  colon.  Tumour cells  are  arranged  in  sheets      
having abundant eosinophilic cytoplasm with vesicular nuclei and  
prominent  nucleoli  admixed  with  lymphocytic  infiltrate.  It  has  good  
prognosis.
(22)
    
OTHER RARE VARIANTS: 
Clear  cell  variant 
Spindle  cell  variant 
Carcinosarcoma 
Trophoblastic  variant 
Anaplastic  variant 
Neuroendocrine  differentiation 
Hepatoid  differentiation 
Rhabdoid  variant 
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Glassy  cell  variant 
Oncocytic  variant 
Blastoid   variant 
 CLINICAL FEATURES: 
Patients presents with fatigability, weakness, anaemia,  
hematochezia, altered  bowel  habits  or  intestinal  obstruction.  Anaemia  
is  more  common  with  right  side  colonic  tumors.  Left  side  colonic  
tumors  more  commonly  presents  with  features  of  intestinal  
obstruction.  Tenesmus  is  seen  with  rectosigmoid  tumours. 
DIAGNOSTIC  PROCEDURES:  
IMAGING  
          CT,  MRI  and  trans  rectal  ultrasonography  are  not  only  useful  
in  detecting  colorectal  carcinoma  they  are  also  useful  in  assessing   
the  depth  as  well  as  the  extent   of  the  tumour.  They  also  detect  
regional  and  distant   lymph  node  metastasis  which  is  useful  for  
staging  the  tumour.  
The  other  imaging  modalities  that  can  be  used  are  positron  
emission  tomography   and  scintigraphy.   
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TISSUE SAMPLING  
Colonoscopy  and  sigmoidoscopy  guided  biopsy  are  helpful  in  
establishing the diagnosis  of  colorectal  cancer   
INDICATIONS OF COLONOSCOPY 
a. For  screening  high  risk  people 
b. Evaluation   and  removal  of  polyp 
c. Current  or  previous  bowel  resection  for  colon  cancer 
d. Positive  family  history  of  cancer 
e. Management  of  inflammatory  bowel  disease 
f. Detection  of  acute  bleeding  sites  
g. Decompression  of  colon  
ROLE OF IMMUNOHISTOCHEMISTRY IN COLORECTAL 
CANCER: 
  The  immunohistochemical  markers  used  in  colorectal  carcinoma  are 
1. MUC1  and  MUC3 
2. CYTOKERATIN  20 
3. P53 
4. CARCINO EMBRYONIC ANTIGEN 
5. CDX2 
6. HER2 NEU 
7. Cathepsin 
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8. TAG  72 
9. Villin 
10. PLAP 
MUCINS: 
Mucins are of several types. They are MUC1, MUC2, MUC3,  
MUC5AC  and  MUC 6. These are glycoproteins expressed by epithelial  
cells. Conventional colorectal carcinoma most commonly express  MUC1   
and  MUC3.Mucinous   carcinoma   express  MUC2. 
MUC 13  expression  is  seen  in  poorly  differentiated  carcinoma. 
MUC5AC   is  expressed  in  pancreatico  biliary  tumors  and  negative  
in  colorectal  carcinoma.  Expression  of  mucin  is  also  seen  in  other  
malignancies  such  as  gastric,  pancreatic  and  breast  tumors.   
CYTOKERATIN 20: 
CK20 is a protein found mainly in gastric and intestinal mucosa.  
Colorectal carcinoma are commonly positive for CK20 and are negative 
for CK7
(23)
. This helps in differentiating colorectal adenocarcinoma  from  
adenocarcinoma  of  ovary,  lung  and  prostate. CK20  positivity  is  also  
seen  in  merkel  cell carcinoma  and  transitional  cell carcinoma.  
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P53: 
P53 is a tumor suppressor protein which is located on the short arm 
of chromosome17.  Its main function is to identify the DNA  damage  in  
a  cell  and  repair  the  DNA  damage  by  arresting  the cell  cycle  at  
G1/S  regulation  point. If the repair of the DNA fails then the apoptosis 
of the cell is mediated.  P53 gene mutation is seen in many tumours.  P53  
mutation associated with colorectal cancer have poor prognosis and  
reduced  survival  rate 
CARCINOEMBRYONIC ANTIGEN IN COLONIC   
CANCER: 
CEA is a glycoprotein which  is  involved  in  cell  adhesion.  CEA  
is expressed in tumors such as lung, gastric, breast, thyroid and  
pancreatic  tumors. It is used as a tumor marker in these conditions.  Non 
neoplastic conditions expressing CEA are pancreatitis, ulcerative colitis,  
COPD,  hypothyroidism,  cirrhosis  and  crohn  disease. 
CDX2: 
CDX2   is  a  homebox  gene  and  it  is  mainly  involved  in  the  
proliferation  and  differentiation  of  intestinal  epithelial  cells
(24)
. 
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Majority of the colorectal adenocarcinoma express CDX2. CDX2  
expression  is   also  seen  in  other  tumours  such  as  lung,  ovary,  
bladder and  pancreaticobiliary  tumours. 
HER 2 /neu 
Human  epidermal  growth  factor   receptors  are  involved  in  the  
regulation  of  cell  growth  by  activating  multiple  signal  transduction  
pathway.  The HER family consists of HER1, HER2, HER3 and HER4. 
HER2 is  located  on  the  chromosome  17q21.   HER  2  overexpression  
and  amplification  is  seen  in  colorectal  cancer,  breast  cancer,  ovarian  
cancer,  oesophageal  cancer  and  gastric  cancer.  HER 2   is  used  as  a  
theranostic  marker.   
CATHEPSIN B: 
Cathepsin  B  expression  is  found  in  colorectal  carcinoma  and  
in  a  wide  array  of  disease. 
TAG72:  
 Tumour   associated  glycoprotein  is  expressed  in  many  tumours  
such  as  colon, ovary, breast  and  pancreatic  tumours.Expression  of  
TAG  72  is  mainly  seen  in  invasive  colorectal  tumours.  It is  also  
expressed   in  normal  mucosa,  adenomatous polyp  and  hyperplastic  
polyp. 
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VILLIN  
Villin  is  an  actin  binding  protein  seen  in  the  brush  border  of   
microvilli.  Colorectal  adenocarcinomas  express  villin. 
PLAP: 
ALP gene produces  an enzyme called  PLAP.  It is expressed  in  
colorectal  carcinoma,seminoma  and  ovarian  cancer. 
STAGING: 
The  following  are  the  staging   systems   for  colorectal  carcinoma. 
       -Duke’s  classification  
       -Staging  system of  Astler  and  Collar 
       -Staging  system  by  American  Joint  Committee 
       -TNM  Classification  of  staging 
1.Duke’s  Classification 
    In   1937   duke’s   classification  was  proposed.  
Stage  A-  only  the  wall  of  the  bowel  is  involved  by  the  
tumour. 
Stage B-  Tumour  extends  through  the  bowel  wall.      
Stage C-  Tumours  having  lymph  node  metastasis 
C is further  subclassified  into  C1  and  C2 
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Stage C1-  involvement  of  regional  lymph  nodes. 
Stage  C2-  where  nodes  at  mesenteric  blood  vessels  were  involved 
Stage  D-  Distant  metastasis 
2. Astler  and  Collar  Classification 
This was proposed in 1954. 
Stage A - Tumour limited to mucosa 
Stage B1  -   Tumour  involves   Muscularis  externa  but  does  not  
penetrate through  it  
Stage B2    - Tumour  penetrates  through  Muscularis  externa 
Stage  C1    -  Tumour  is  confined  to   the  bowel  wall  with  nodal  
metastasis 
Stage  C2    -  Tumour  penetrates  through  the  bowel  wall  with  nodal                       
metastasis 
3.TNM  classification: 
      Primary   tumour 
     TX           Primary  tumour  cannot  be  assessed 
     T0           No  evidence  of  primary  tumour 
     Tis          carcinoma  in  situ:  intraepithelial  or  invasion  of  lamina   
propria 
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     T1          tumour  invades  Submucosa 
     T2          Tumour  invades  Muscularis  propria 
     T3          Tumour  invades  through  the  Muscularis  propria  into  
  pericolorectal  tissues 
   T4a  Tumour penetrates through the surface of  the visceral   
peritoneum 
  T4b  Tumour  directly   invades  or  is  adherent  to  other  organs   
or  structures. 
REGIONAL LYMPH NODES 
     NX Regional  lymph  nodes  cannot  be  assessed   
     N0  No  regional  lymph  node  metastasis 
     N1  Metastasis  in  1-3  regional  lymph  nodes 
     N1a Metastasis  in  1  regional  lymph  nodes 
     N1b Metastasis  in  2-3  regional  lymph  nodes 
N1c tumour deposits in the subserosa, mesentry, or non  peritonealised   
pericolic or perirectal tissues without regional node metastasis 
      N2          Metastasis in 4 or more regional lymph nodes 
     N2a Metastasis in  4  - 6  regional  lymph  nodes 
30 
 
     N2b Metastasis in 7 or more regional lymph  nodes
(70) 
METASTASIS 
M0 No distant metastasis 
M1     Distant metastasis 
          M1a   Metastasis  confined  to  one  organ  or  site(  liver,  lung,   
ovary,  non  regional  node) 
        M1b     Metastasis  in  more  than  one  organ/site   or  the   
    peritoneum 
 STAGE GROUPING 
  Stage 0 Tis        N0        M0 
  Stage I T1         N0       M0 
T2          N0      M0 
Stage  II        T3          N0     M0 
                      T4          N0    M0 
Stage   III      Any T        N1           M0 
                      Any T       N2            M0  
Stage   IV     Any  T       Any  N     M1 
 
AJCC GRADING 
GX        Grade   cannot  be   assessed 
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 G1        Well  differentiated 
G2         Moderately  differentiated 
G3         Poorly  differentiated 
G4         Undifferentiated 
PROGNOSTIC FACTORS IN COLORECTAL CANCER: 
AGE:  
Age  is  an  important  factor  in  rectal  tumours  rather  than  
colonic  tumours. Tumour  presentation  at  very  younger  age  and  very  
older  age  carries  poorer  prognosis. 
SEX: 
     Males  have  poorer  outcome  when  compared  to  females. 
CEA SERUM LEVELS:  
       Patients with  CEA  level  more  than  5ng/ml  has  poorer  outcome. 
TUMOUR LOCATION: 
       Tumours situated in the left colon carries good prognosis. Tumours  
located  at  sigmoid  colon  and  rectum  have  poorer  outcome.   
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TUMOUR SIZE:  
      Poor  prognosis  is  seen  in  both  smaller  tumour  size  and  larger  
tumour  size. 
TUMOUR EDGE: 
Sessile and ulcerated tumours have worst prognosis when 
compared with  polypoid  tumours.   
TUMOUR MARGIN AND INFLAMMATORY REACTION:  
 Better outcome  is  seen  with  tumours  having  pushing  margins.  
Better  prognosis  is  seen  when  there  is  presence  of  inflammatory  
infiltrate   at  the interphase  between tumour. 
LOCAL EXENT: 
When  the  involvement  of  tumour  is  confined   only  to  mucosa  
and submucosa  it  carries  good  prognosis  whereas  tumours  presenting  
with  perforation  or  involving  all  the  layers  of  bowel  wall  have  
poorer  outcome. 
TUMOUR BUDDING: 
When  there  are  isolated  tumour  cells  or  clusters  of  more  than  
5  cells  at the  invasive  front  it  indicates  poorer  outcome
(27)
.Tumour  
budding  represent   epithelial-mesenchymal   transition  which  is  
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considered  to  be  an  early  step   in  tumour  invasion  and  
metastasis
(28)
.Tumour  budding  can  be  identified  by  cytokeratin  
especially  in  areas  where  tumour  bud  is  obscured  by  peritumoural  
inflammatory  infiltrate. 
VASCULAR INVASION: 
Tumours  identified  with  the  presence  of  vascular  invasion  
have increased chance of distant metastasis indicating  poor  prognosis
(54)
.  
The  prognostic  significance  is  more  with  tumours  involving  the  
extra  mural blood  vessels  rather  than  intramural  blood  vessels.  
PERINEURAL INVASION:  
    Tumours with perineural invasion have poorer outcome. It 
indicates advanced  disease . 
PERICOLONIC TUMOUR DEPOSITS:  
     Poor  prognosis  is  seen  with  the  tumours  having  pericolonic  
tumor   deposits
(59)
. 
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SURGICAL MARGIN: 
Anastamotic  recurrence  is rare  if  the  resection  margins  are  > 
5cm from the tumor.  Involvement of radial margin in rectal carcinoma  
has  poorer  outcome. 
MICROSCOPIC TYPE AND PATTERN: 
Medullary  carcinoma  have  better  outcome  whereas  mucinous  
carcinoma,  signet  ring  carcinoma  and  anaplastic  carcinoma have 
poorer  outcome.  Patients  with  mucinous  carcinoma  show  minimal  
response  to chemotherapy  and  targeted   genes(20). Tumours with 
microacinar pattern have   better outcome. 
GENETIC FACTORS: 
 Tumours  with  the  expression  of  mucin  related  antigens  such  
as  sialyl-TN  and  sialyl-Lewis (X), expression  of  fascin, expression  of  
PR6  and P16INK 4  has  poorer  outcome
(73)
.   
       Tumours  with  loss  of  claudin -1  and  with  allelic   loss  of   
chromosome 18q  have  poor  prognosis.  Tumors  with  Bcl-2  protein  
expression,   HLA-DR  expression  and  TGF-beta1  mutations   have  
better  outcome. 
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LYMPH NODE INVOLVEMENT: 
Tumours  with  numerous  metastatic  nodes  and   presence   of  
nodes which are very distant from the tumour  have poor  prognosis
(29)(30)
.  
Decreased survival rate is seen in tumours with lymph node  involvement. 
PATTERN OF LYMPH NODE REACTION: 
Presence  of  reactive  changes   in  a   node  produced   by   cell  
mediated immune   response  carries  good  prognosis.   
STAGING AND GRADING:  
     Staging  and  grading  are  important  prognostic  indicators 
SPREAD AND METASTASIS:   
The  spread  of  the  tumour  can  be  in  the  following  way 
1. Direct  spread 
2.  Lymphatic  spread 
3. Hematogenous  spread 
DIRECT SPREAD:  
The   tumour  spreads  to  the  nearby  structures  by  invading  
through  muscularis  propria  into  pericolic /perirectal  soft  tissues. 
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LYMPHATIC SPREAD: 
  
 The  commonest  site  of  metastatic  involvement  by  a  tumour  is  
a lymph  node.  Lymph node metastasis has greater prognostic  
significance
(31)
.  A  minimum  of  14  or  15  lymph  nodes  must  be  
retrieved  from  the  surgical  specimen  of  colorectal  tumours.  Isolated  
tumour   nodules  named  pericolonic  tumour  deposits  are  not   
considered  as  lymph  node  metastasis.  They  are  seen  in  perivascular 
perineural  or  intravascular  location. 
HEMATOGENOUS SPREAD: 
Hematogenous  spread  is  mainly  by  portal  vein  invasion  in  
colon  tumours  and  venacaval  invasion  in  rectal  tumours. The  
commonest  metastatic  sites  are  liver,  lung  and  ovary.  The rare 
metastatic  sites  of  colonic  tumours  are  central  nervous  system,  
bone,  testis,  uterus   and  oral  cavity. 
TREATMENT:  
 Surgical  resection  is  the  mainstay  of  treatment  and  it  is  
mainly  based  on  the  site  of  the  tumour.  If   the tumour is found   in 
caecum and right colon then  right  hemicolectomy  is  done.  For  
tumours  involving  proximal  or  middle  transverse  colon  extended  
right  hemicolectomy  is  done.  If  the  tumour  is  found  in  splenic  
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flexure  and  left  colon,  left  hemicolectomy  is  done.  For tumours 
involving  sigmoid  colon,  sigmoid  colectomy  is  done.   
Total  abdominal  colectomy  with  ileorectal  anastamosis  is  done  
for  patients  with  attenuated  FAP,  HNPCC,  metachronous  cancer  in  
separate  colonic  segments.  Other  treatment  options  are  cryotherapy,  
radiofrequency  ablation  and  hepatic  arterial  infusion  of  
chemotherapeutic  agents.  Systemic  chemotherapeutic  agents  used  to  
treat  colorectal  cancer  are  5  Fluorouracil,  capecitabine,  oxiplatin  and  
irinotecan. 
REPORTING CHECKLIST FOR COLORECTAL CANCER. 
1.LOCATION  OF  THE  TUMOUR: 
Location  of  the  tumour  is  very  important  especially  in  case   
of  sigmoid   colon  and  rectal  cancers   where  the  prognostic   features  
and treatment  are  different .  Rectum  and  sigmoid  colon  are  
differentiated  by mesentry,  taenia  coli  and  peritoneum.  Sigmoid  
colon  has  mesentry  and taenia  coli  whereas  in  rectum  they  are  
absent. Sigmoid  colon  is  completely  covered  by  peritoneum  whereas  
in  rectum  it  is  covered  by  peritoneum  on  its  anterior  and  lateral  
sides  in  the  upper  third.  In  the  middle  third  of   rectum  the  
peritoneal  covering  is  seen  on  its  anterior  aspect  and  in  distal  third  
the  peritoneal  covering  is  completely  absent. 
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2. SIZE AND CONFIGURATION OF THE CANCER 
         The tumour can be exophytic,  endophytic or diffusely infiltrative 
3.STATUS  OF  RESECTION  MARGIN 
The resection margins   are   proximal, distal and circumferential  
(radial/ mesenteric margin). Recurrences are rare if the resection margins 
are > 5cm from the tumour. The resection margins are better examined  
before  subjecting the  specimen to formalin.  Circumferential resection  
margin  is  positive  when  the  tumour   is  present  <0.1  cm  from  the  
margin. If  the  tumour  is  present  very  close  to  the  resection  margin  
then  perpendicular  sections  has  to  be  taken  for  histopathological  
examination.  For  circumferential  resection  margin  close  to  a  tumour  
atleast  two  perpendicular  sections  are  recommended  because  there  is  
a  problem  underestimating  a  positive  margin  by  50%  with  a  single  
section.   
Positive  circumferential  margin  has  a  higher  rate  of  local  
recurrence  and  distant  metastasis  and  it  carries  poor  prognosis
(32)(33)
.     
EVALUATION OF MESORECTUM: 
Local  recurrence  is  rare  when  the  rectum  is  completely  
exicised along  with  surrounding  soft  tissues(34). 
39 
 
Complete excision of  mesorectum  is  considered 
1. When the mesorectum removed is bulky with a smooth surface. 
2. When the mesorectal  surface  has  minor  irregularities. 
3. When the surgical margin has no surface defects greater than  
0.5cm. 
4. When  the  distal  margin  of  the  specimen  has  no  coning 
5. When  the  resected  circumferential  margin  after  tranverse  
sectioning  appears  smooth 
Near  complete  exicision  of  mesorectum  is  considered 
 
1. When  the  resected  mesorectum  bulk  is  moderate. 
2. When  there  are  irregularities  in  the  mesorectal  surface  defects  
greater  than  0.5  cm  but  not  extending  into  Muscularis  
propria. 
3. When  the  Muscularis  propria  is  not  seen  except  at  the  
insertion  of  levator  ani  muscle. 
Incomplete exicision of mesorectum is considered   
1. when  there  is  only  little  bulk  in  the  mesorectum 
2. when  the  defects  in  the  mesorectum  extends  down  to  
   muscularis  propria 
3. when  the  circumferential  margin  appears  irregular  on  
   transverse section. 
40 
 
LYMPH NODE STATUS: 
 The  lymph  node  status  is   determined  by  the  following  factors. 
1. Patients  age 
2. Gender 
3. Tumour  depth 
4. Grade  of  the  tumour 
5.  Location  of  the  tumour 
6. Extent  of  resection  of  the  tumour 
Lymph  nodes  must  be  adequately  evaluated  for  accurate  staging. 
After   formalin  fixation  the  resected specimen has to be manually  
dissected for lymph nodes. A minimum of 12 nodes must be  
harvested
(35)
.  The  lymph  node yield  can  be   increased  by  fat  clearing  
and methylene blue staining. Preoperative chemotherapy and  
radiotherapy  also  influences  the  lymph  node  status.   The  lymph  
node  metastasis  in  colorectal  cancer  are  usually  smaller  than  5mm. 
Intranodal  tumour  cell  clusters   are  defined  as  isolated  tumour  cells  
less  than  0.2mm
(36)(37)
. Intranodal  tumour  cell  clusters   are  classified  
as  pN0(i+)   and  are  not  considered  metastasis. Presence of single  
cells  and  small  clusters  in  the  lymph  node   are  not  considered  
metastasis. Nodes are positive when there are tumour foci  showing  
glandular differentiation, stromal  reaction,  distended  sinus  or  invasion. 
These are staged under pN1. When  the  tumour  cell  clusters  are  greater  
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than  0.2mm  but  less  than  2mm  they  are  considered  as  
micrometastasis and are staged as pN1mi. IHC and molecular  techniques  
like  reverse  transcriptase  PCR  can  diagnose occult  metastasis.Isolated  
tumour cells and micrometastasis can be differentiated by using CK20. 
DEPTH OF PENETRATION OF THE TUMOUR  
Atleast  three  sections  of   the  tumour  taken  perpendicular  to 
the  bowel  wall  has  to be  evaluated    
LYMPHOVASCULAR INVASION  
 Lymphovascular invasion has an adverse prognostic significance. 
There is a high level of  interobserver  variability  and  underreporting  in  
venous  invasion
(57)
.H  and  E  stain  and  Elastic  stain  can   be  used  to  
determine  venous  invasion. 
EXTRANODAL TUMOR DEPOSITS 
These are discontinuous extramural extension of a tumour.   
Tumour  deposits  in  the  absence  of  lymph  node  metastasis  were  
categorised  under  N1c   category
(37)
.      
PERITONEAL ELASTIC LAMINAL INVASION 
The peritoneal elastic lamina invasion in colorectal cancer carries  
poor prognosis.  PELI  is  an  important  predictive  factor  for  lymph  
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node  metastasis  and  recurrence  free  survival  in  patients  with  T3  
colorectal  cancer
(38)
.  In  pathological  staging  of  colorectal  carcinoma,  
tumor  invading into pericolorectal tissues are considered  as  T3  whereas  
tumour  invading the  visceral  peritoneum  are  considered  as  T4. When  
the  tumour  involves  the  peritoneal  surface,  instead of  smooth  surface  
it  exhibits  peritoneal  clefts  or  reflections.   The criteria  for  visceral    
peritoneal  invasion  are   
 Tumor  present  at the  serosal  surface  with  inflammatory   
reaction, mesothelial  hyperplasia  and  erosion/ulceration. 
 Free tumour  cells  on  the  serosal  surface  with  underlying   
ulceration of  the  visceral  peritoneum
(40)(46)
. 
 
There  is  significant  association  of  PELI  with  lymphovascular 
invasion, lymph node  metastasis  and  recurrence. Therefore  T3  
tumours with  peritoneal  elastic  lamina  invasion  should  be  considered  
as T4
(38)(39)
.  
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FIG 1:  Shows Gross image of colonic carcinoma with  serosal  
involvement 
Longitudinal section from the arrowed area without pericolic fat 
should be taken and compared with non cancerous area to assess PELI 
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FIG 2:   Shows  schematic  diagram  of  colorectal wall with elastic 
lamina 
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As like  pericardial  cavity   and  pleural  cavity  ,the  peritoneal  
cavity  are  lined  by  serosal  membrane. The serosal  membrane  has  
three  layers.  They  are  mesothelial  layer,  submesothelial  layer  and  
basement  membrane. The  submesothelial  layer has  elastic  lamina. It  
is  a  reticular  meshwork  of  interwoven  elastic  fibres
(69)
.  These   fibres  
appear  thick  on  light  microscopy.  The  elastic  lamina  in  the  
submesothelial  layer  can  be  highlightened  by  elastic  stain
(41)(42)
. PELI  
invasion  is  better  visualized  with  elastic  stain   rather  than  H  and  E  
stain.  Elastic  lamina  in  colon  cancer  can be  intact,  fragmented,  
attenuated, splayed  or  absent 
(43)
.   
The elastic lamina will  be  retracted  in  deeply  invasive  tumours. 
Tumour invasion of peritoneal membrane is associated  with  
proliferation of serosal  stromal  cells  which  are  keratin  positive
(44)(45)
.If  
the  elastic  lamina  is  difficult  to  diagnose,  then  its  location  can  be  
identified   from  the  area  of  transition  between  the  keratin  positive  
and  keratin  negative  stromal  cells   of  peritoneal  and  extraperitoneal  
tissues  respectively. 
CANCER  MICROENVIRONMENT  FORMED  BY  ELASTIC  
LAMINA  INVASION(CMPI) 
This  is  a  specialized  tumour  area  which  is  present  between  
the peritoneal  elastic  lamina  and  peritoneal  surface  formed  due  to  
46 
 
elastic  lamina  invasion. There is heterogenous microenvironment  
within  a  single  tumour.  At   the  periphery  of  CMPI,  tumour  budding  
and  macrophages  were  observed and at the centre of CMPI fibrosis  and  
abundant  extracellular  matrix  components  were  prominent. PELI  can  
be  of  elevated  type  or  non elevated  type. In  elevated  type  of  PELI  
the  elastic  lamina  is  drawn  towards  the  tumour  and  it  has  a  larger  
CMPI area with high  tumour  annularity  and  prominent lateral tumour  
spread. Elevated type of ELI is more frequently associated with intestinal  
obstruction.  
 
FIG 3:  shows  CMPI  formed  by  tumour  a) gross  b)H and  E  c) 
Elastic  stain   
Elevated type of ELI 
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ROLE OF SUBPERITONEAL FIBROBLASTS IN   
COLORECTAL CANCER PROGRESSION 
Subperitoneal  fibroblasts(SPFs)  which  is  found  between  
peritoneal  elastic lamina  and  peritoneal  surface    plays  an  important  
role  in  cancer  progression  and  metastasis
(44)
.  The  distance  between  
peritoneal  elastic lamina  and  peritoneal  surface  is  100micrometres  
thick  which  mainly contains subperitoneal  fibroblasts  and  extracellular   
matrix components. Subperitoneal  fibroblasts  reciprocally  interacts  
with cancer cells and facilitates tumour progression  and  metastasis. 
SPFs produces larger number of cytokines leading to failure of  peritoneal  
dialysis.  SPFs express  alpha  smooth  muscle  actin  and  has  prominent  
contractile  ability.  Alpha  smooth  muscle  actin  expression  causes  
tissue  elasticity  which  is  associated  with  tumour  metastasis.   
LYMPHOVASCULAR INVASION IN COLORECTAL CANCER 
Vascular  invasion  in  colorectal  cancer  is  considered  to  be   an 
independent  prognostic  factor
(61)
.  Vascular  invasion  can  be  of  blood 
vessel  invasion  or  lymphatic  vesssel  invasion  .Blood  vessel  invasion  
and  lymphatic   invasion  has  to  be  differentiated  as  they  have  
different  clinical  implications. Blood  vessel  invasion  correlates  with  
visceral  metastasis  and  lymphatic    invasion  correlates   with  lymph  
node  metastasis. Vascular  invasion  can  be  of  intramural  or  
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extramural. When  the  vascular  invasion  is  seen  in  the  submucosal  or  
muscular  layer  it  is  considered  to  be  intramural  invasion.  When  the  
vascular  invasion  is  seen  beyond  muscularis  propria  it  is  considered  
to  be  extramural  invasion. Extramural    invasion  has  a  strong  adverse  
outcome
(47)(48)(49)
.  Detection of venous  invasion  helps  oncologist  in   
planning  adjuvant  chemotherapy.   
The  factors  that  facilitate  the  increased detection  of  venous  
invasion  are  increased  number  of  tumour  blocks  and  tangential  
sectioning  of  peritumoural  mesocolic/mesorectal  fat.  Venous  invasion  
is  considered  when  the   tumour  cluster  is  covered  more  than  half  
of  its  circumference   by  elastic  membrane  or  when  the  tumour  is  
covered   atleast  half  of  its  circumference  by  endothelial  cell. Venous  
invasion  is  better  assessed  with  elastic  stain  rather  than  H  and  E   
stain. Venous  invasion  is  overlooked  when  the  muscular  wall  of  the  
vein  is  obliterated   beyond  morphologic  recognition  or  altered  by  
post  operative  radiation.  The  residual  vessel  wall  in  these  areas  are  
highlightened  by  elastic  stain.   
The   morphologic  clues   to  think  about  venous  invasion  in  
colorectal  carcinoma  are  orphan  arteriole  sign (where the tumour 
nodule is present adjacent to a muscularized  artery)  and  protruding  
49 
 
tongue  sign  (where  there  is   smooth  bordered  protrusion of  tumour  
into  pericolic  fat  adjacent  to  a  artery)
(51)
.   
The  confounding  factors  in  lymphovascular  invasion  are  the  
retraction  artifact,  stromal  fibroblast  which  resemble  like  endothelial  
cell  and  knife  carry  over  artifact.  The   immunohistochemical   stain  
used   to   demonstrate  lymphatic  and  small  blood  vessel  invasion  are  
CD  31  and  CD  34.  Lymphatic  invasion  can  be  identified  by  using  
markers such as  D2-40 and LYVE  -1
(50)
.  Patients  with  lymphovascular  
invasion  have  higher  chance  of  lymph  node  metastasis  . 
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MATERIALS AND METHODS 
STUDY DESIGN: 
       Prospective and  retrospective  study 
PLACE OF STUDY: 
Department of pathology, Coimbatore Medical College  Hospital, 
Coimbatore. 
STUDY PERIOD: 
        June 2015 - June 2017  
INCLUSION CRITERIA 
Resection  specimens  for  colonic  carcinoma   from  all  age  
group  with  T3  and  T4  colorectal  cancers 
EXCLUSION CRITERIA  
1. Specimens  with  T1  and  T2  colorectal  cancers 
2. Tumours  below  peritoneal  reflection 
3. Recurrent  tumours   
4. Tumours  in  which  grossing  was not representative 
5. Treated  cases 
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The received specimens were adequately fixed and processed.   
Representative  samples  were  taken  which  included  areas  in  which  
the  tumour had  maximum  depth  and  minimum  clearance  from  the  
radial margin. Care was taken to avoid peritoneum with adherent  
pericolic  fat.   
Inking  of  such  samples  was  avoided  to  enable  easy  
identification  of  elastic  lamina.  A  minimum  of  2  samples  were  
taken  for  each  case. 
H  and  E  stained  slides  were  reviewed  without  the  knowledge  
of  the  stage  of  colorectal  cancer.  Elastic  stain  was  performed  on  all  
the  slides  using  internal  control  and  external  control.  Identification  
and  intactness  of  elastic  lamina  was  studied  in  all  the  cases  and  
recorded.  In  addition  presence/absence  of  vascular  invasion  was  
noted  in  all  the  cases. 
  Elastic lamina  invasion  was  considered  positive   
1. When  breach  was  readily  identifiable  or 
2. When  the   tumour  was  present  beyond  the  level  of  residual  
elastic lamina  and  associated  with  significant  inflammatory  
response 
52 
 
An appropriate way to identify the subserosal elastic lamina in a 
cancerous area is to follow it from a non cancerous and non desmoplastic 
area. 
The  following  details  were  recorded  in  each  case  -  details  of   
the  patient,  tumour  location,  histologic  grade,nodal  status  and  
presence  or  absence  of  vascular  invasion. 
Histologic  grading  was  done  as  follows 
Well  differentiated  grade-  >95%  of  the  tumour  cells  show  glandular   
formation. 
Moderately  differentiated  grade-  50-95%  of  the  tumour  cells  show  
glandular  formation.  
Poorly  differentiated  grade-  <50%  of  the  tumour  cells  show  
glandular  formation.  
Diagnosis  is  obtained  based  on  the  histomorphological  features. 
METHOD OF HAEMATOXYLIN AND EOSIN STAINING 
REAGENTS USED: 
1. Erlich`s  Haematoxylin  solution 
2. 1%  Eosin  Y  solution 
3. 1%  Acid  alcohol  solution 
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PROCEDURE: 
1. Sections  were  deparrafinized  by  immersing  in  xylene  for  30  
seconds 
2. Sections   are then placed  in  Isopropyl  alcohol   for  15  minutes. 
3. Wash in running  tap  water. 
4. Sections were then stained with  Erlich`s  Haematoxylin  solution. 
5. Wash  in  running  tap  water. 
6. Differentiate  with  acid  alcohol  1%  solution  -2  to  3  dips 
7. Blueing  is  done  for  10  minutes. 
8. Counterstain  is  done  with  eosin  1%  solution-  3  to  4  dips. 
9. Wash  in  tap  water. 
10. Sections  are  air  dried 
11. Dip  in  xylene  and  mount  in  DPX. 
ELASTIC  STAINING 
VERHOFF  METHOD 
a. Haematoxylin   -  5gm 
          Absolute  alcohol  -  100ml 
b. Ferric  chloride  -  10gm 
          Distilled  water  -  100ml 
c. Lugol`s  iodine  solution   
          Iodine  -  1gm 
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         Potassium  Iodide  -  2gm 
        Distilled  water  -  100ml 
d. working  solution 
Solution  (A)  -20ml 
 Solution  (B)  -  8ml 
 Solution  (C)  -  8ml 
Add  in  the  above  order  and  in  between  addition  mix 
METHOD 
1. Dewax  sections  and  bring  to  water. 
2. Cover  with  staining  solution  for  30  minutes. 
3. Rinse  in  water. 
4. Differentiate  in  2%  aqueous  ferric  chloride  until  elastic  fibres  
appear  black  on  grey  background. 
5. Rinse  in  water 
6. Dip  in  95%  alcohol  to  remove  any  staining  due  to  iodine  
alone. 
7. Counterstain  with  Van  Gieson  solution  for  1-2  minutes. 
8. Blot  dry  to  remove  excess  stain. 
9. Dehydrate  clear  and  mount 
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VAN GIESON SOLUTION 
Filter  when  using 
Acid  fuschin  1%                                -  2.5ml(0.25ml) 
Picric  acid  saturated  aqueous        -  97.5ml(9.75ml) 
RESULTS 
Elastic fibres will  appear  black.  
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OBSERVATION AND RESULTS 
         The present study was conducted in the  Department of Pathology,  
Coimbatore  Medical  College  Hospital.  It is both retrospective and  
prospective.  A  total  of  50  cases  of  colorectal  specimens  which  were  
received  during  June  2015  to  June  2017  were  studied.  Ethical  
clearance  was  obtained  from  ethics  committee  of  Coimbatore  
Medical  College  Hospital,   Coimbatore. 
Peritoneal  elastic  lamina  invasion  and  extramural  venous  
invasion  in  colorectal  cancer  were  studied  using  elastic  stain  and  
their significance in staging was observed. 
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Table 1: Mean age of the study 
 
 
No  of  
cases 
Minimum Maximum Mean 
Standard 
Deviation(SD) 
 
AGE 
 
50 33 80 57.18 12.36 
 
The mean age of the present study is 57.18 
 
Table 2: Age distribution in colon cancer 
Age distribution Number Percent (%) 
<40 Years 9 18.0 
41-60 Years 22 44.0 
61-80 Years 19 38.0 
 
In   the  present  study,  the  incidence  of  colorectal  cancer  is  
more  common  in  the  age  group  between  41-60  yrs  comprising  
about  44%  of  cases  followed  by  61-80  yrs  and  <40  yrs  constituting  
38%  and  18%  cases respectively.  
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CHART 1: AGE DISTRIBUTION IN COLORECTAL CANCER 
 
 
 
The  incidence  of  colorectal  cancer  is  illustrated  in  the  above  
diagram.  41-60yrs is  the  most  commonly  affected  age  group. 
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Table 3: Gender distribution in colon cancer 
Sex Number Percent (%) 
Male 
28 56.0 
Female 
22 44.0 
  
 As  per  the  present  study,  colorectal  cancer  is  more  common  
among  males  constituting  about  56%  of  cases. 
CHART 2:  GENDER  DISTRIBUTION  IN  COLORECTAL  
CANCER 
 
  
The  bar  diagram  shows  that  out  of  50  cases,  28  cases  were  
males  and  22  cases  were  females. 
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Table 4: Site of tumour involvement in colon cancer 
Site of Tumour Number Percent (%) 
Ascending colon 4 8.0 
Caecum 3 6.0 
Caecum and ascending 
colon 
4 8.0 
Descending colon 3 6.0 
Ileum and caecum 3 6.0 
Rectum 11 22.0 
Sigmoid colon 12 24.0 
Sigmoid colon and 
rectum 
7 14.0 
Transverse colon 3 6.0 
 
As  per  the  present  study,  the  most  commonly  affected  sites  
of colonic cancer are  sigmoid  colon  followed  by  rectum  constituting  
about  24%  and  22%   of  cases  respectively.  Involvement   of  both  
sigmoid  colon  and  rectum  occurs  in  about  14%  of  cases. 
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CHART 3:  DISTRIBUTION OF SITE OF TUMOUR 
INVOLVEMENT IN COLORECTAL CANCER 
 
 
 
From  the  above  chart  it  was  observed  that  the  most  common  
affected  sites  of  colorectal  carcinoma  were  sigmoid  colon  and  
rectum. 
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TABLE 5: HISTOLOGICAL TYPE IN COLON CANCER 
Histological type Number Percent (%) 
Adenocarcinoma 39 78.0 
Adenocarcinoma with 
mucinous differentiation 
2 4.0 
Malignant melanoma 1 2.0 
Mucinous 
adenocarcinoma 
5 10.0 
Neuroendocrine 
carcinoma 
2 4.0 
Signet  ring  cell 
carcinoma 
1 2.0 
 
 The  above  table  shows  that  adenocarcinoma  is  the  most  
common  histological  type  of  colorectal  cancer  constituting  about  
78%  of  cases.   
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CHART 4: DISTRIBUTION OF HISTOLOGICAL TYPES IN 
COLORECTAL CANCER 
 
 The  above  bar  diagram  illustrates  that  the  adenocarcinoma  is  
the  most  common  histological  type  of  colorectal  cancer. 
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TABLE 6: HISTOLOGICAL GRADE IN COLON CANCER 
Grade Number Percent (%) 
WDG 18 36.0 
MDG 20 40.0 
PDG 2 04.0 
Others 10 20.0 
 
  
In the present study, 40% of cases were moderately differentiated  
and  36% of cases were well differentiated. Poorly differentiated grade 
contributes about 4% of total cases.    
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CHART 5:  DISTRIBUTION OF HISTOLOGICAL GRADE IN 
COLORECTAL CANCER 
 
 
 The  above  chart  shows  that   most  of  the  colorectal  cancers  
were  moderately  differentiated  and  well  differentiated. 
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TABLE 7: TUMOUR STAGING 
Tumour Number Percent (%) 
T3 44 88.0 
T4 6 12.0 
 
 In   the  present  study  of  50  cases,   44   cases   were   T3  and   6  
cases   were   T4. 
CHART 6: TUMOUR STAGING IN COLORECTAL CANCER 
 
 
 
The  above  chart  shows  the  distribution  of  T3  and  T4  cases.   
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TABLE 8: LYMPHOVASCULAR INVASION IDENTIFIED WITH 
H AND E  STAIN 
Lymphovascular 
Invasion 
Number Percent (%) 
Present 4 8.0 
Absent 46 92.0 
 
 In  the  present  study,  out  of   50  cases  4  cases   were  identified  
with lymphovascular   invasion. 
CHART 7:  LYMPHOVASCULAR  INVASION  IDENTIFIED  
WITH  H  AND  E  STAIN 
 
 
The  bar  diagram  shows  that  lymphovascular  invasion  was  
identified  in  4  cases  with  H  and  E  stain  
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TABLE 9: VISCERAL PERITONEAL INVASION IDENTIFIED 
USING ELASTIC STAIN 
Tumour 
No of cases in which 
elastic lamina 
identified 
No of cases  
showing visceral 
peritoneal 
invasion 
P value 
T3 24(88.8%) 3(11.2%) 
.007* 
T4 6(50.0%) 6(50.0%) 
  
*-STATISTICALLY SIGNIFICANT (P<0.05) (Chisquare test) 
Elastic lamina was identified   in 30 cases.  Out of  24 cases  which  
staged  as  T3,  3  cases   showed   visceral  peritoneal   invasion. These 3 
cases  were  concluded  as  T4  after   elastic  stain.  
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Chart 8:  Visceral  Peritoneal  Invasion  Identified  Using  Elastic  
Stain 
 
 
 
 
The  bar  diagram  shows  that  3  case  of  T3  showed  visceral  
peritoneal  invasion 
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TABLE 10: VENOUS INVASION WITH H AND E STAIN AND 
ELASTIC STAIN 
Tumour 
staging 
No of cases 
showing venous 
invasion with H 
and E Stain 
No of cases  
showing venous 
invasion with 
elastic stain 
P value 
T3 
 
2(33.3%) 4(66.7%) 
.651 
T4 
 
2(40.0%) 3(60.0%) 
 
 INFERENCE:  2  cases  of  T3  and  1  case  of  T4   were   found  
to  have   venous  invasion  using   elastic  stain  in  addition  to  the   four  
cases   identified   by  H  and  E  stain.  
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CHART  9:  VENOUS  INVASION  WITH  H  AND  E  AND  
ELASTIC  STAIN 
 
  
The  bar  diagram  shows  that  4  cases  were  identified  with  
venous  invasion  with  H  and  E  stain.  7 cases showed  venous  
invasion  with  elastic  stain 
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Table  11:Correlation  of  grade  of  tumour,  nodal  metastasis,  
visceral  peritoneal  invasion(elastic  stain)  and  venous  
invasion(elastic  stain)  in  T3  tumours: 
 
Hpe  no staging grade 
Nodal  
metastasis 
Visceral  
peritoneal  
invasion 
Venous  
invasion 
2187/15 T3N2aMx WDG present present present 
826/16 T3N1aMx MDG present absent present 
1695/17 T3N1aMx 
Adenocarcinoma 
With  mucinous 
differentiation 
present present present 
2392/17 T3N1bMx MDG present present present 
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Table  12:Correlation  of  grade  of  tumour,  nodal  metastasis,  
visceral  peritoneal  invasion(elastic  stain)  and  venous  
invasion(elastic  stain)  in  T4  tumours: 
 
Hpe.  
No 
Staging Grade 
Nodal  
metastasis 
Visceral  
peritoneal  
invasion 
Venous  
invasion 
2172/16 T4N2bMx PDG Present Present Present 
2421/16 T4N0Mx MDG Absent Present Absent 
2814/16 T4N0Mx MDG Absent Present Absent 
4021/16 T4N1bMx MDG Present Present Present 
1614/17 T4aN2bMx 
Mucinous 
adenocarcinoma 
Present Present Present 
2584/17 T4aN1cMx 
Mucinous 
adenocarcinoma 
Absent Present Absent 
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COLOUR PLATES 
 
FIG: 4 H & E: T3 MUCINOUS ADENOCARCINOMA (4X) 
 
 
FIG:5 H&E:T4  MUCINOUS  ADENOCARCINOMA (4X) 
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FIG 6: H & E VISCERAL PERITONEAL INVASION (4X) 
 
 
              
FIG 7: H & E VISCERAL PERITONEAL INVASION (10X) 
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FIG:8 H&E:T4    MUCINOUS  ADENOCARCINOMA  (10X)  
 
 
 
FIG:9  H & E  EXTRAMURAL  VASCULAR  INVASION  (10x) 
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FIG:10  H & E  EXTRAMURAL  VASCULAR  INVASION  
(40x)   
 
FIG 11.ELASTIC STAIN  -  NORMAL ELASTIC LAMINA(4X) 
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FIG 12. ELASTIC  STAIN  -  NORMAL  ELASTIC  LAMINA(10X)  
 
 
  
FIG 13.ELASTIC  STAIN  THICK  ROPY  ELASTIC  LAMINA  
(10X) 
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FIG 14.ELASTIC STAIN NORMAL VESSEL WALL (10X) 
 
 
 
FIG 15.ELASTIC  STAIN:  FRAGMENTED  ELASTICLAMINA 
T4 (4X) 
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FIG 16.ELASTIC  STAIN:  FRAGMENTED  ELASTIC  LAMINA 
T4.(10X) 
 
FIG 17. ELASTIC STAIN  FRAGMENTED ELASTIC LAMINA 
WITH INVASION (40X) 
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FIG 18. ELASTIC STAIN  FRAGMENTED  ELASTIC  WITH 
INVASION LAMINA (100 X)  
 
FIG 19. ELASTIC STAIN  INDRAWN ELASTIC LAMINA (4X) 
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FIG 20. ELASTIC  STAIN  INTRAMURAL  VASCULAR  
INVASION  (10X)   
 
FIG 21 . ELASTIC STAIN EXTRAMURAL  VASCULAR  
INVASION  (10X) 
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FIG 22. ELASTIC  STAIN  EXTRAMURAL  VASCULAR  
INVASION(40X) 
 
FIG 23. ELASTIC STAIN EXTRAMURAL VASCULAR 
INVASION (40X) 
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DISCUSSION 
This  study was conducted  in  the  Department  of  pathology,  
Government  Medical  College,  Coimbatore  and included  a  total  of  50  
cases.  Colorectal cancer  is  one  of  the  commonest  cancer  which  is 
 prevalent   worldwide.  It  is  commonly  seen  in  60  to  70  yrs  of  age 
 group  and  usually  affects  males.  It  is  multifactorial  in  etiology. The 
 prevalence  of   colorectal  carcinoma  in  developed  countries     is 
 more   when  compared  with  developing  countries.  
TNM  staging  system  was  developed  by  AJCC  to  provide  an 
 accurate prediction  of  clinical  outcome.  There is  lot  of  controversery 
 in assessing  the  serosal  involvement  in  colorectal  cancer  due  to 
 interobserver variations  compounded by variation in sampling methods 
 and  lack  of  adequate  sections. 
The  role  of  elastic  stain  as   a  surrogate  marker  has  been 
studied,  although  its  usefulness  as  a  predictor  of  serosal  invasion 
has  not been  proved.  Elastic stain  has  also  been  used  to  confirm 
 vascular invasion as it is an independent  prognostic  factor.  The 
 importance  of  distinguishing  stage  2  and   stage  3  colorectal  cancer 
 is  underscored  by  the  fact  that  adjuvant  chemotherapy  is  considered 
 only  in  stage  3 cancer. 
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Age at presentation 
The  mean  age  of  the  present  study  was  57.18  yrs(range  of 
 33 – 80). The  mean  age  of  other  studies  such  as  Grin  et  al(43) ,  
yukihiro et al
(39) 
and  Gouda  YG
(80)
 et  al  were  72,   67.75  and  49.34yrs  
respectively. 
Comparision of mean age in different studies 
STUDY MEAN  AGE 
Present  study 57.18yrs 
Grin  et  al
(43) 
72yrs 
Yukihiro  et  al
(39) 
67.75yrs 
Gouda  YG  et  al
(80) 
49.34yrs 
 
Gender distribution 
In  the  present  study  among  50  patients,  28(56%)  are  males 
 and 22(44%)   are  females  showing  male  preponderance.  This  is 
comparable  to  a  study  conducted  by  Gouda  YG  et  al
(80)
  and  
Yukihiro  et  al
(39)
.   
Location of the tumour 
In  the  present  study,  sigmoid  colon  and  rectum  are  the  most  
commonly  affected  sites  of  colorectal  cancer  which  is  comparable  
with  previous  studies  Grin  et  al
(43)
  and  Shinto  et  al
(42)
. 
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Histological  type 
In our study adenocarcinoma was the most common histological  
type constituting about 78% of the cases. These observations were  
similar  to  observations  made  by  WHO.   
Histological  grade 
Among  50  cases,  40%  of  the  cases  were  moderately 
differentiated  and  36%  of  the  cases  were well  differentiated.  This  is  
comparable  to  the  results  obtained  by  Grin  et  al
(43)
  and   Yukihiro  et  
al
(39)
 
Lymphovascular  invasion  in colorectal  cancer 
Venous invasion has an independent prognostic significance in 
colorectal  cancer. Venous invasion is underreported in colorectal cancer. 
 Extramural venous invasion has  an  adverse  outcome.   
In  the  present  study  out  of  50  cases  7  cases  showed  venous  
invasion with elastic stain. With  H and  E  stain  it  could  be  detected  in  
4  cases.   
The interpretation of this variable is limited by interobserver  
variation.   
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The  probability  of  missing  lymphovascular  invasion  is  high  
and  is  influenced  by  the  area  which  is  being  sampled.   
Messenger  et  al  
(54)
  observed  a  3  fold  increase  in  the 
 detection  of  venous  invasion  after  using  elastic  stain. 
 Roxburgh  et  al
(52)
    studied  venous  invasion  in  419  patients 
 and  observed  venous  invasion  in  58%  of  cases  after  elastic  stain. 
Only  18%  of  cases  showed  venous  invasion  with  H  and  E  stain. 
Betge  et  al
(48)
   and  Roxburgh  et  al
(52)
  found  that  venous  
invasion  is  an  independent  predictor  for  survival. 
Betge  et  al
(48)
  and  Messenger  DE
(54)
  et  al  found  that  the  
detection  of  venous  invasion  can  be  increased  by  increasing  the  
number  of  blocks. 
Comparision of elastic stain detected VI in different studies 
STUDY 
NO  OF  
CASES 
VI(H&E) 
VI                
(ELASTIC 
STAIN) 
Present  study 50 4 7 
Howlett  et al
(56) 
92 18 62 
Sejben  et  al
(58) 
89 18 71 
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Visceral  peritoneal  invasion 
In  our  study  elastic  lamina was identified  in  30  cases.  Among 
24 T3 cases, 3 cases showed peritoneal elastic  lamina  invasion.  6 cases  
belonging to T4 stage showed  identifiable visceral  peritoneal  invasion. 
Grin  et  al  (2013)  studied   217  cases  of  which  186  cases  were 
 T3  and  31  were  T4.  Out  of   186  cases  of  T3,  121  cases  did  not  
show  elastic  lamina  invasion,  31  cases  showed  elastic  lamina   
invasion  and  in  34  cases  elastic  lamina  could  not  be  identified.   
 They  observed  that  there was  no  significant  difference  in  disease 
 free  survival    between  ELI positive  and  negative  tumours  and 
 concluded  that  elastic  lamina  invasion doesn’t  have  prognostic 
 significance. They  also  observed  that  in  right sided  tumours   elastic 
 lamina  could  not  be  easily  identifiable.   
Yukihiro  et  al(2016)  in  their  study  observed   139  T3  cases 
 for  peritoneal  elastic  lamina  invasion  .They  found  that  23%  of  the 
 T3  cases  were  found  to  have  peritoneal  elastic  lamina 
 invasion.They  did  elastic  stain  on  only  one  section  having  deepest 
 tumour  invasion.   
They  observed  that  there  is  a  significant  association  of  PELI 
 with  lymph  node  metastasis and  recurrence  free  survival  rate  and 
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 concluded  that  T3  tumours  with PELI  should  be  treated  like   T4a 
 tumours.      
Kojima  et  al   (2010)  studied  PELI  in  564  cases  of  T3  and 
 T4a   colorectal  cancer. They  found  PELI  in  44%  of  cases  and  
included with  atleast 4 sections for each case for  evaluation. 
 Eventhough  they examined  multiple  slides  they  were  not  able  to 
 appreciate  elastic  lamina  in  a  small  proportion  of  cases.  They 
 assessed  following  morphologic  parameters  like  depth  and  width  of 
 the  tumour  ulcer,  depth  of  tumour  invasion  beyond  the  muscle  coat 
 and  degree  of  fibroinflammatory response   associated  with  retracted 
 peritoneal  surface.  They  concluded  that ELI  was  an  independent 
 risk  factor  for  recurrence  in  stage  2  colorectal cancer. 
Liang  et  al  (2013)  studied  244  cases  of  T3  colorectal  cancer. 
 They observed  PELI  in  41%  of  cases  of  which  24.6%   showed 
 displayed elastic  lamina  invasion.  They  did  elastic  stain  on  only 
 one  section  and  also  observed  that  the  disease  free  survival  and 
 overall  survival  rate  was poor  for  tumours  with  PELI.  They  advised 
 elastic  stain  for  routine  use  in  T3  colorectal  cancer.  
Yokota  et  al  (2014)   studied   436  patients  of  T3  and  T4a 
 colorectal  cancer.  They  found  PELI  in  44%  of  cases  examined 
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 with  a  mean  of  4  sections.  They  concluded  that  tumours  with 
 PELI had adverse  prognostic  significance.   
study 
No  of  sections 
 stained 
%  of  PELI 
 postivity 
Present  study 1 18% 
Kojima  et  al
(40) 4 44% 
Yokota  et  al
(79)  
4 
41.7% 
Liang  et  al
(38) 1 24.6% 
Yukihiro  et  al
(39) 1 23% 
 
Possible source of  this  variation  may  be  due  to 
1. Differences   in  the  sampling  method  and  also  the  number  of  
samples  included  in  the  study. 
2.  Retrospective  analysis  prevents  the  possibility  of  resampling 
3. Limiting  the  number  of  elastic  stains  to  sections  in  which  the   
tumour   was  close  to  the  serosa.  
4. Presence of peritoneal clefts and reflections.  
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SUMMARY 
 This  study  was  conducted  in  the  Department  of  Pathology,  
Government  Medical  College  Coimbatore. 
 The  study  was  done  on  colorectal  cancer  resected  specimens  
from all  age  group  with  T3  and  T4  staging. 
 A  total  of  50  cases  were  studied.  Among  50  cases  44  were  
T3  and  6  cases  were  T4. 
 Most  patients  belonged  to  the  age  group  41-60  yrs  and  males  
predominated  56%. 
 Sigmoid  colon  and  rectum  are  the  most  common  affected  
sites  of  colon. 
 Majority  of  the  cases(78%)  were  adenocarcinoma. 
 40%  of  the  cases  were  of  moderately  differentiated  grade. 
 With  H  and  E  stain,  4  cases  showed  lymphovascular  
invasion. With  elastic  stain  7  cases  showed  lymphovascular  
invasion. 
 9 cases  showed  visceral  peritoneal  invasion  with  elastic  stain  
and  was  statistically  significant 
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CONCLUSION 
Elastic stain is useful to evaluate serosal invasion and  
lymphovascular  invasion  in  colorectal  carcinoma.  The  value  of  
subserosal  elastic  lamina  invasion  becomes  significant  in  patients  
with  pN0M0  status  provided  a  standard  protocol  becomes  approved  
in  future  for  correct  sampling  of  specimens  which  increases  the  
chances  of  identification  of  elastic  lamina  in  significant  proportion  
of  cases.  This  should  be  done  along  with  follow  up  studies  to  
assess  the  survival  rate  for  better  correlation.  Hence  the  use  of  
elastic  stain  in  colorectal  cancer  should  be  regularly  done  to  assess  
the  depth  of  invasion  and  more  importantly  to  provide  better  
treatment. 
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ANNEXURE I 
PROFORMA 
COIMBATORE MEDICAL COLLEGE 
DEPARTMENT OF PATHOLOGY 
COIMBATORE 
Particulars of the patient: 
Name  :                                         IP/OP NUMBER: 
Age:                                              Ward number: 
Sex:                                                occupation:        
Address: 
Presenting complaints: 
Change  in  bowel  habits 
Blood  in  the  stool 
Loss  of  weight,  loss  of  appetite 
Family history: 
Malignancy +/- 
Personal history:smoker 
GENERAL PHYSICAL EXAMINATION: 
Built:                                                               Febrile : 
Nourishment :                                                 Pallor: 
Conscious :                                                    Jaundice: 
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Weight :                                                        Cyanosis: 
Pulse rate:                                                     Clubbing: 
Respiratory rate :                                          Lymphadenopathy: 
SYSTEMIC EXAMINATION: 
RS:                                                P/A: 
CVS:                                              CNS: 
CLINICAL DIAGNOSIS: 
RADIOLOGICAL FINDINGS: 
USG: 
CT: 
MRI: 
MICROSCOPIC FINDINGS: 
Histopathological diagnosis: 
Elastic  stain: 
FINAL DIAGNOSIS: 
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ANNEXURE II 
ABBREVIATION 
1.  FAP -  Familial  Adenomatous  Polyposis 
2.  APC - Adenomatous  Polyposis  Coli  
3.  MYH -   Myosin  heavy  chain 
4.  MLH1 - Mut  L  Homolog  1 
5.  MSH2 - Mut  S  protein  Homolog  2 
6.  MSH6 - Mut  S protein  Homolog  6 
7.  PMS2 - Post  Meiotic  Segregation  Increased  S.Cerevisiae,2 
8.  MSI - Microsatellite  instability 
9.  MSI H -  Microsatellite  instability high 
10.  MSI L - Microsatellite  instability  low 
11.  EMAST - Elevated  Microsatellite  Alteration  at  Selected   
   Tetranucleotide Repeats 
12.CIMP - CpG  Island  Methylated  tumour 
13.CIMP-H - CpG  Island  Methylated  tumour  high 
14.CIMP-L - CpG  Island  Methylated  tumour  low 
15.TP16 - Tumour  protein  p16 
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16.TP53 - Tumour  protein  p53 
17.CDH1 - cadherin – 1 
18.K-RAS - Kristen  rat  sarcoma  gene 
19.CT - Computed  tomography 
20.MRI - Magnetic  resonance  imaging 
21.MUC1 - Mucin  1 
22.MUC3 - Mucin  3 
23.CEA - Carcino  embryonic  antigen 
24.CDX2 - Caudal  type  homeobox  2 
25.TAG72  - Tumour  associated  glycoprotein  72 
26.PLAP - Placental  alkaline  phosphatise 
27.HCG - Human  chorionic  gonadotropin 
28.ALP - Alkaline  phosphatise   
29.PP  - Pancreatic  polypeptide 
30.PYY - Peptide  YY 
31.CD31 - Cluster  of  differentiation  31 
32.CD34 - Cluster  of  differentiation  34 
33.LYVE1 - Lymphatic  vessel  endothelial  hyaluronan  receptor 1 
34.PR6 - Pathogenesis  related  protein  6 
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35.BCL2 - B cell  lymphoma  2 
36.HLA DR - Human  leukocyte  antigen  -  antigen  D  related 
37.TGF beta -   Transforming  growth  factor  beta 
38.TNM - Tumour,  node  and  metastasis  staging 
39.AJCC - American  joint  committee  on  cancer 
40.APR - Abdomino  perineal  resection 
41.PELI - Peritoneal  elastic  lamina  invasion 
42.CMPI - Cancer  microenvironment  formed  by  peritoneal   
   invasion 
43.SbF - Subperitoneal  fibroblast 
44.ACF - Aberrant  cryptic  foci 
45.MDF - Mucin  depleted  foci 
46.BCAC - beta  catenin  accumulated  crypts 
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ANNEXURE III 
MASTER CHART 
S.NO 
HPE   
NO 
AGE SEX 
HISTOLOGIC  
TYPE 
GRADING 
NODAL  
STATUS 
STAGING 
LVI(H 
&E) 
PELI(ELASTIC 
STAIN) 
LVI(ELASTIC  
STAIN) 
1 1157/15 70 M AD MDG N2b T3 A A A 
2 1232/15 60 M MAD OTH N2b T3 A A A 
3 1411/15 42 F AD MDG N0 T3 A A A 
4 1833/15 45 M AD WDG N0 T3 A A A 
5 2136/15 64 M AD WDG N1c T3 A A A 
6 2187/15 72 M AD WDG N2a T3 A P P 
7 2274/15 55 M SRC OTH N2a T3 A A A 
8 2460/15 40 F AD WDG N0 T3 A A A 
9 2878/15 47 F AD WDG N0 T3 A A A 
10 3322/15 60 M AD WDG N1a T3 A A A 
11 3745/15 58 F AD WDG N0 T3 A A A 
12 008/16 80 M AD MDG N0 T3 A A A 
13 91/16 51 M AD MDG N1a T3 A A A 
14 102/16 60 F NEC WDG N1a T3 A A A 
15 552/16 63 F AD WDG N0 T3 A A A 
16 826/16 65 M AD MDG N2a T3 P A P 
17 859/16 80 F AD MDG N1a T3 A A A 
18 897/16 64 M AD WDG N1a T3 A A A 
114 
 
S.NO 
HPE   
NO 
AGE SEX 
HISTOLOGIC  
TYPE 
GRADING 
NODAL  
STATUS 
STAGING 
LVI(H 
&E) 
PELI(ELASTIC 
STAIN) 
LVI(ELASTIC  
STAIN) 
19 1961/16 33 M AD WDG N0 T3 A A A 
20 2172/16 65 M AD PDG N2b T4 A P P 
21 2210/16 58 F AD MDG N1c T3 A A A 
22 2421/16 58 F AD MDG N0 T4 A P A 
23 2581/16 70 M AD MDG N0 T3 A A A 
24 2614/16 36 M AD PDG N0 T3 A A A 
25 2814/16 63 F AD MDG N0 T4 A P A 
26 3098/16 68 M AD MDG N0 T3 A A A 
27 3696/16 40 M AD WDG N1b T3 A A A 
28 3752/16 47 F AD MDG N0 T3 A A A 
29 4021/16 53 F MAD MDG N1b T4 A P P 
30 4352/16 60 M AD OTH N0 T3 A A A 
31 520/17 39 F AD WDG N1b T3 A A A 
32 668/17 70 F AD MDG N1b T3 A A A 
33 997/17 68 F AD WDG N0 T3 A A A 
34 1287/17 40 M AD MDG N0 T3 A A A 
35 1319/17 70 M AD MDG N0 T3 A A A 
36 1531/17 59 M AD WDG N0 T3 A A A 
37 1614/17 55 M MAD OTH N2b T4 P A A 
38 1653/17 36 F AD WDG N0 T3 A P P 
39 1695/17 35 M ADMD OTH N1a T3 P P P 
40 1706/17 40 F AD MDG N1b T3 A A A 
41 2372/17 57 M MAD OTH N0 T3 A A A 
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S.NO 
HPE   
NO 
AGE SEX 
HISTOLOGIC  
TYPE 
GRADING 
NODAL  
STATUS 
STAGING 
LVI(H 
&E) 
PELI(ELASTIC 
STAIN) 
LVI(ELASTIC  
STAIN) 
42 2392/17 67 F AD MDG N1b T3 A P P 
43 2431/17 47 F AD WDG N0 T3 A A A 
44 2556/17 70 F AD MDG N0 T3 A A A 
45 2584/17 78 M MAD OTH N1c T4 P P A 
46 2675/17 60 M MM OTH N1a T3 A A A 
47 2720/17 56 F ADMD OTH N0 T3 A A A 
48 2800/17 60 M NEC OTH N1b T3 A A A 
49 3106/17 65 M AD MDG N0 T3 A A A 
50 3143/17 60 F AD WDG N0 T3 A A A 
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KEY TO MASTER CHART 
M  - Male 
F  - Female 
AD  - Adenocarcinoma 
MAD  - Mucinous  adenocarcinoma 
SRC  - Signet ring cell carcinoma 
NEC  - Neuroendocrine carcinoma 
ADMD - Adenocarcinoma  with  mucinous  differentiation 
MM  - Malignant melanoma 
WDG  - Well differentiated grade 
MDG  - Moderately differentiated grade 
PDG  - Poorly differentiated grade 
OTH  - Others 
A  - Absent 
P  - Present 
 
 
